Nanostics Announces Collaboration to Develop Diagnostic Tools for Urological Diseases
Nanostics announced an agreement with Alberta Health Services to help drive diagnostic and prognostic innovations in urological care.
Read MorePosted by Andy Lundin | Apr 9, 2024 | Urinalysis & Toxicology |
Nanostics announced an agreement with Alberta Health Services to help drive diagnostic and prognostic innovations in urological care.
Read MorePosted by Andy Lundin | Apr 8, 2024 | Prostate |
A study investigating a single invitation to a PSA blood test to screen for prostate cancer found it had a small impact on reducing deaths.
Read MorePosted by Andy Lundin | Mar 29, 2024 | Prostate |
MRI of the prostate, combined with a blood test, can help find if a prostate lesion is clinically significant cancer, new research suggests.
Read MorePosted by Andy Lundin | Mar 21, 2024 | Cancer |
Ibex’s Galen platform aims to help labs overcome the challenges of increasing demand and diagnostic workloads for cancer diagnostics.
Read MorePosted by Chris Wolski | Mar 18, 2024 | Lab Automation |
CLP Editor Chris Wolski explains how he got over his fears of lab automation and why it might be right for your workflow.
Read More